PROFESSIONAL EDITION

The largest community of pharma leaders

Errant Gene Therapeutics, LLC (“EGT”) Pushing Clinical Trial of Potentially Curative Treatment for Beta-Thalassemia and Eventually Sickle Cell Disease

TAMPA, Fla.–(BUSINESS WIRE)–Errant Gene Therapeutics, LLC pushing Clinical Trial of potentially curative treatment for beta-thalassemia and eventually Sickle Cell Disease
Source Read More

Recent Articles